Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (271-280 of 441) with videos related to

Pageof 45
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 11, 2020
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy toolsLorenzo Gerratana, Andrew A Davis, Maurizio Polano, et al.
Cancer|October 19, 2011
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancerStacy Moulder, Gregory Gladish, Joe Ensor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancerFrancisco J Esteva, Vicente Valero, Daniel Booser, et al.
Annals of Surgical Oncology|August 18, 2004
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapyJeannie Shen, Vicente Valero, Thomas A Buchholz, et al.
Cancer Research|December 3, 2014
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell linesDaniela Sicoli, Xuanmao Jiao, Xiaoming Ju, et al.
International Journal of Cancer|March 10, 2011
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapyMichal Mego, Sendurai A Mani, Bang-Ning Lee, et al.
Cancer|August 19, 2007
Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique diseaseMassimo Cristofanilli, Vicente Valero, Aman U Buzdar, et al.
Plos One|January 26, 2016
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood SamplesPriya Gogoi, Saedeh Sepehri, Yi Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2018
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3Massimo Cristofanilli, Angela DeMichele, Carla Giorgetti, et al.
NPJ Breast Cancer|June 2, 2021
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancerRui Luo, Weelic Chong, Qiang Wei, et al.
Pageof 45

Showing results (271-280 of 441) with videos related to

Sort By:
Pageof 45
European Journal of Cancer (Oxford, England : 1990)|December 11, 2020
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy toolsLorenzo Gerratana, Andrew A Davis, Maurizio Polano, et al.
Cancer|October 19, 2011
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancerStacy Moulder, Gregory Gladish, Joe Ensor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancerFrancisco J Esteva, Vicente Valero, Daniel Booser, et al.
Annals of Surgical Oncology|August 18, 2004
Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapyJeannie Shen, Vicente Valero, Thomas A Buchholz, et al.
Cancer Research|December 3, 2014
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell linesDaniela Sicoli, Xuanmao Jiao, Xiaoming Ju, et al.
International Journal of Cancer|March 10, 2011
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapyMichal Mego, Sendurai A Mani, Bang-Ning Lee, et al.
Cancer|August 19, 2007
Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique diseaseMassimo Cristofanilli, Vicente Valero, Aman U Buzdar, et al.
Plos One|January 26, 2016
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood SamplesPriya Gogoi, Saedeh Sepehri, Yi Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2018
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3Massimo Cristofanilli, Angela DeMichele, Carla Giorgetti, et al.
NPJ Breast Cancer|June 2, 2021
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancerRui Luo, Weelic Chong, Qiang Wei, et al.
Pageof 45